XKDCT086
/ First Condor Biotech, Celconta Group
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 20, 2023
Exploratory Clinical Trial on the Safety, Efficacy, and Pharmacokinetics of XKDCT086 (iPD-1-Claudin18.2-CAR-T) in Claudin 18.2 Positive Advanced Solid Malignant Tumors: a Single Center, Single Arm, Dose-increasing Trial
(clinicaltrials.gov)
- P=N/A | N=9 | Recruiting | Sponsor: The Affiliated Hospital of Qingdao University
Metastases • New trial • Gastric Cancer • Gastrointestinal Cancer • Oncology • Solid Tumor • CLDN18
1 to 1
Of
1
Go to page
1